转质氨酶2在人类腹膜透析相关的腹膜损伤中
Shunnosuke Kunoki1,2, Masashi Ikeno3, Hideki Tatsukawa4
1Department of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Aichi, Japan.
Physiological reports
|September 22, 2025
概括
转胺酶2 (TG2) 在腹腔透析并发症,如纤维化中发挥关键作用. 抑制TG2对治疗腹膜透析诱导的腹膜纤维化和封装腹膜硬化有希望.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 长期腹膜透析 (PD) 可能导致腹膜纤维化和血管生成,损害膜功能.
- 转胺酶2 (TG2) 对于细胞外基质稳定性至关重要,并与纤维化有关.
- 之前的动物研究表明,TG2抑制可以减少腹膜纤维化,血管生成和炎症.
研究的目的:
- 为了研究PD患者的人类腹组织中的TG2表达.
- 探索TG2在高葡萄糖诱导的中细胞病理生理学中的作用.
- 评估TG2在腹损伤中的参与及其作为治疗点的潜力.
主要方法:
- 分析了163个人类腹膜组织样本 (对照组,PD溶液,腹炎,EPS).
- 在各种细胞类型中对TG2表达的免疫组织化学研究.
- 在体外研究中使用培养的中皮细胞暴露于高葡萄糖,TG2抑制剂和TGF-β1 siRNA.
主要成果:
- 在受伤的腹膜中,TG2的表达上调,在腹炎中最高.
- TG2水平与膜厚度,巨细胞和肌纤维细胞的增加相关.
- 高葡萄糖诱导的原-1,TGF-β1和TG2在中皮细胞中;TG2抑制或TGF-β1敲击降低了这些效应.
结论:
- 在PD期间,TG2与腹损伤的发病有关.
- 高葡萄糖透析剂通过TGF-β和TG2的相互作用导致腹膜纤维化.
- 准TG2为PD并发症和EPS提供了潜在的治疗策略.
相关概念视频
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
557
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
557
Acute Kidney Injury II: Pathophysiology
903
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
903
Kidney Transplant II: Surgical Procedure
320
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
320
Peritoneal Dialysis I: Introduction and Procedure
2.4K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
2.4K
Gastritis-II: Pathophysiology
1.2K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
833
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
833


